The use of muscle-enhancing steroids, particularly anabolic-androgenic steroids (AAS), has sparked widespread concern about their effects on cardiovascular health, notably their link to heart attacks. This presentation provides a comprehensive assessment of the link between muscle-enhancing drugs and heart attacks. It investigates the physiological pathways by which steroids might contribute to a variety of cardiovascular issues such as hypertension (high blood pressure), dyslipidaemia (abnormal cholesterol levels), atherosclerosis (plaque build-up in arteries), and thrombosis (blood clot formation). Furthermore, it examines the epidemiological evidence linking steroid usage to an increased risk of heart attacks and other cardiovascular events. The abstract also delves into the ethical quandaries surrounding steroid usage in sports and fitness, as well as regulatory actions aimed at preventing steroid abuse. Finally, it emphasizes the crucial need for multidisciplinary teamwork and evidence-based solutions in addressing this public health challenge. This abstract, in essence, stresses the importance of raising awareness, expanding research efforts, and implementing strong prevention activities to reduce the cardiovascular hazards linked to muscle-enhancing drugs and advocate safer alternatives to achieving fitness goals.
IJPRAS
